WebManager HR Industrial Products. Dez. 2024–März 20241 Jahr 4 Monate. Bonn, Nordrhein-Westfalen, Deutschland.
Cardionovum® Begins In Vivo Testing of Its Paclitaxel-Coated …
WebCardionovum GmbH. Am Bonner Bogen 2, 53227 Bonn Germany . PHONE: +49 22 89 09 72 269 FAX: +49 22 81 80 91 909 Visit Website. View US Listing. Created with Sketch. Created with Sketch. Balloons / Drug-Coated Balloons View Chart. Company Name Product Name Drug Type ... WebCARDIONOVUM, a medical technology company based in Bonn, Germany, develops and commercialises innovative medical devices such as new generation DCBs and drug-eluting stents for the treatment of coronary and peripheral artery disease. ... Cardionovum GmbH. Cardionovum. SIC Code 38,384. NAICS Code 33,339. Show More. Cardionovum Org … ksat weather doppler radar san antonio
CARDIONOVUM GmbH LinkedIn
WebDec 5, 2024 · CARDIONOVUM Life deserves the best. Innovative cardiovascular therapies for a better patient care. Cardionovum feels competent for further developments in leading edge … Massimo Morero Chief Technology Officer Monika Mroczkiewicz QA & RA Director … Since the beginning in 2013, Cardionovum is represented in more than 40 countries … XLIMUS DES® Sirolimus eluting coronary stent system. XLIMUS is the ultimate … Microscopy of the ‘SAFEPAX’ balloon surface showing no visible PTX … Yanqi Yin - Yaxue Shi, et al., The American Journal of Kidney Diseases P19-27.E1, … Bonn, Germany. November 16, 2024 – Data presented at Innovation session today at … APERTO DCB® Paclitaxel releasing high pressure shunt balloon dilatation … Pre-clinical results confirm no noticeable embolization results similar to POBA. … WebCARDIONOVUM GmbH, Bonn, Amtsgericht Bonn HRB 14153: Gewinn, Patente, Umsatz, Mitarbeiter, Netzwerk, Wirtschaftsinfos. ... CARDIONOVUM GmbH. MSO - GmbH … WebApr 12, 2014 · BONN, Germany, Dec. 4, 2014—Cardionovum GmbH announced today that it has initiated a 150-patient clinical study of its novel paclitaxel-releasing, high-pressure shunt balloon dilatation catheter, APERTO®. The study aims to sustain the highly promising and significant first clinical evidence for APERTO. k sat weather in san antonio texas